What development phase is 5-Methyl-7-Bromo-8-Hydroxyquinoline in?

5-Methyl-7-Bromo-8-Hydroxyquinoline is FDA-approved (marketed).

What is the generic name of 5-Methyl-7-Bromo-8-Hydroxyquinoline?

TILBROQUINOL is the generic (nonproprietary) name of 5-Methyl-7-Bromo-8-Hydroxyquinoline.

Last reviewed 2026-04-20 · How we verify

5-Methyl-7-Bromo-8-Hydroxyquinoline (TILBROQUINOL)

FDA-approved withdrawn Small molecule Quality 6/100

At a glance

Generic name	TILBROQUINOL
Drug class	tilbroquinol
Modality	Small molecule
Therapeutic area	Other
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

5-Methyl-7-Bromo-8-Hydroxyquinoline CI brief — competitive landscape report
5-Methyl-7-Bromo-8-Hydroxyquinoline updates RSS · CI watch RSS